Budget Amount *help |
¥3,770,000 (Direct Cost: ¥2,900,000、Indirect Cost: ¥870,000)
Fiscal Year 2015: ¥1,300,000 (Direct Cost: ¥1,000,000、Indirect Cost: ¥300,000)
Fiscal Year 2014: ¥2,470,000 (Direct Cost: ¥1,900,000、Indirect Cost: ¥570,000)
|
Outline of Final Research Achievements |
We aimed at detecting micrometastasis from abdominal lavage fluids of patients with pancreatic cancer. Using a Competitive Allele -Specific TaqMan(R); PCR (Cast-PCR), point mutations at KRAS codon 12 were tested. A serial dilution experiment of the AsPC-1 cell showed that low concentration as 0.1% of mutant DNA was successfully detected. Accelerated DNA extraction kits enabled us to extract genome DNAs from lavage fluids. KRAS mutation was found in 18 (35%) of 51 patients with pancreatic cancer. Of them, nine patients were diagnosed as negative in lavage cytology. Expression levels of CK19, CK20 and CEA mRNA no significant correlations with the results of lavage cytology. Patients with micrometastasis in the abdominal lavage fluids tended to have a shorter disease-free survival.
|